APA (7th ed.) Citation

Karrar, O., Abdelmagid, M., Rana, M., Iftikhar, M., McCullough, K., Al‐Kali, A., . . . Gangat, N. (2024). Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival. American journal of hematology, 99(2), E63-E66. https://doi.org/10.1002/ajh.27180

Chicago Style (17th ed.) Citation

Karrar, Omer, et al. "Venetoclax Duration (14 Vs. 21 Vs. 28 days) in Combination with Hypomethylating Agent in Newly Diagnosed Acute Myeloid Leukemia: Comparative Analysis of Response, Toxicity, and Survival." American Journal of Hematology 99, no. 2 (2024): E63-E66. https://doi.org/10.1002/ajh.27180.

MLA (9th ed.) Citation

Karrar, Omer, et al. "Venetoclax Duration (14 Vs. 21 Vs. 28 days) in Combination with Hypomethylating Agent in Newly Diagnosed Acute Myeloid Leukemia: Comparative Analysis of Response, Toxicity, and Survival." American Journal of Hematology, vol. 99, no. 2, 2024, pp. E63-E66, https://doi.org/10.1002/ajh.27180.